Glenmark Generics Limited

Supplier Manufacturer,
India


Glenmark Generics Ltd. (GGL) has structured its businesses as US Generics, European Generics, the Active Pharmaceutical Ingredient (API) business and the Oncology Business. A subsidiary of Glenmark Pharmaceuticals Limited, GGL focuses on developing, manufacturing, selling and the distribution of generics through wholesalers, retailers and pharmacy chains. From APIs to front end marketing capabilities, GGL's businesses are vertically integrated into the generics market, by focusing on key niche segments including Dermatology, Hormones, Controlled Substances, Oncology and Modified Release Produc


Product Categories
API
Products
Expand All | Collapse All
Showing 31 to 40 of 74 Suppliers first | previous | next | last

Garenoxacin (1 variant)

CAS Number: 194804-72-3 | API

Glimepiride (1 variant)

CAS Number: 93479-97-1 | API

Imiquimod (1 variant)

CAS Number: 99011-02-6 | API

Lacosamide (1 variant)

CAS Number: 175481-36-4 | API

Lercanidipine hydrochloride (1 variant)

CAS Number: 132866-11-6 | API

Levocetirizine dihydrochloride (1 variant)

CAS Number: 130018-87-0 | API

Linagliptin (1 variant)

CAS Number: 668270-12-0 | API

Linezolid (1 variant)

CAS Number: 165800-03-3 | API

Lornoxicam (1 variant)

CAS Number: 70374-39-9 | API

Lurasidone (1 variant)

CAS Number: 367514-87-2 | API

Register NOW →

Find new trading partners and manage your transactions through every step of the Pharmaceutical supply chain from Quoting to Shipping. Whether you're a buyer or a supplier the iOPharma platform will benefit your organisation.

Close

loading...
Close

Close